|
JPH1017467A
|
|
Cytotoxicity-alleviating agent
|
|
JPH09309860A
|
|
Chalcone compound and antitumor agent
|
|
JPH07188032A
|
|
Influenza-treating medicine
|
|
JPH0782155A
|
|
Glycyrrhizic acid preparation for rectum
|
|
US5358962A
|
|
Antihypertensive method
|
|
JPH06298646A
|
|
Rectum admininistration preparation containing substrance to promote absorption through mucosa
|
|
JPH06172187A
|
|
Medicine for muscular dystrophy
|
|
JPH06135836A
|
|
Inducer for contra-suppressor cell
|
|
JPH06122623A
|
|
Antineoplastic agent
|
|
JPH05320047A
|
|
Hepatic function improving medicine
|
|
US5622942A
|
|
Percutaneous absorptive anesthetic
|
|
JPH0568584A
|
|
Monoclonal antibody, method for measurement, reagent kit and method for searching using the same
|
|
JPH05163282A
|
|
Sulfur-containing aciclovir derivative and its production
|
|
JPH04159220A
|
|
Hypotensive
|
|
JPH0477428A
|
|
Agent for suppressing proliferation of aids virus
|
|
JPH0399023A
|
|
Percutaneous absorption accelerator and percutaneous absorbing-type formulation using the same
|
|
JPH02304024A
|
|
Agent for suppressing proliferation of aids virus
|
|
JPH0291077A
|
|
Novel oxanosine, imidazole derivative and production thereof
|
|
JPH0242027A
|
|
Transmucosal absorbefacient and pernasal administration agent using said absorbefacient
|
|
JPH0228121A
|
|
Transmucosal absorbefacient and pernasal administering agent using the same absorbefacient
|
